Key takeaway: The investor presentation from Krishna Institute of Medical Sciences Limited (KIMS) dated August 3, 2026, outlines the company's financial results for the first quarter ended June 30, 2026. The presentation highlights a total revenue of Rs. 11,959 million, reflecting a 10.3% increase quarter-over-quarter and a 36.1% increase year-over-year. EBITDA for the quarter was reported at Rs. 2,398 million, with an EBITDA margin of 20.1%. However, profit before tax (PBT) and profit after tax (PAT) showed declines of 50.2% and 56.0% year-over-year, respectively. The presentation also details operational metrics, including an increase in inpatient and outpatient volumes. KIMS emphasized its strategic growth initiatives, including expanding bed capacity and enhancing clinical capabilities across various regions. The document concludes with a summary of the company's corporate structure and key achievements in the quarter.

Key takeaway: On May 18, 2026, KIMS Hospitals held its Q4 FY '26 earnings conference call, where management reported a total revenue of INR 1,084 crore, reflecting a year-on-year growth of 35.3%. EBITDA was reported at INR 216 crore, with a margin of 19.9%, down from 25.3% in the same quarter last year. The company highlighted a total revenue of INR 3,931 crore for FY '26, marking a 28.2% increase year-on-year, but noted a decline in PAT to INR 242 crore from INR 415 crore in FY '25. Management discussed the impact of new hospital openings on financial performance, with new units contributing INR 224 crore in revenue but also incurring EBITDA losses. They emphasized ongoing expansions and the importance of insurance empanelments for future growth. The management expressed optimism about achieving stable growth despite current challenges, including the ongoing Gulf War and its economic ramifications.

Key takeaway: On May 16, 2026, Krishna Institute of Medical Sciences Limited (KIMS) submitted an investor presentation detailing its audited financial results for the fiscal year ending March 31, 2026. The presentation highlighted KIMS's vision to be a leading healthcare provider by offering affordable care and achieving the best clinical outcomes. It outlined the company's operational performance, reporting a 25% CAGR in revenue and a 13% CAGR in EBITDA over the past three years. The financial highlights included total revenue of Rs. 39,308 million for FY26, with a reported PAT of Rs. 2,420 million. The presentation also discussed the company's strategic growth initiatives, including the addition of over 1,300 beds through new facilities and acquisitions. KIMS emphasized its commitment to modern medical technology and patient-centric care, showcasing various specialties and achievements in the healthcare sector.

Key takeaway: On February 9, 2026, Krishna Institute of Medical Sciences Limited (KIMS) held its Q3 FY26 earnings conference call, where management reported record-breaking revenue of INR 1,003 crores, marking a 2.2% year-on-year growth. However, EBITDA declined by 0.4% year-on-year to INR 204 crores, attributed to pressures from new units. The net profit after tax (PAT) was INR 52 crores, down 39.9% year-on-year. Management highlighted operational achievements, including the performance of new hospitals and significant medical procedures. They discussed ongoing expansion plans, including a new hospital in Chennai, and emphasized the importance of skilled workforce development in the healthcare sector. Management expressed confidence in stabilizing new units and achieving growth in the upcoming financial year, while also addressing debt levels and insurance empanelment progress.

Key takeaway: The investor presentation from Krishna Institute of Medical Sciences Limited (KIMS) detailed the company's unaudited financial results for the third quarter and nine months ended December 31, 2025. The presentation highlighted a 26.4% year-over-year increase in operating revenue, reaching 28,300 million rupees for the nine-month period. However, the company reported a decline in profit before tax (PBT) and profit after tax (PAT) compared to the previous year, attributed to higher finance costs and depreciation. KIMS emphasized its commitment to providing affordable healthcare and maintaining operational excellence, with a focus on expanding its bed capacity and enhancing clinical services across various specialties. The presentation also outlined strategic initiatives for growth, including partnerships with doctors and the introduction of advanced medical technologies. KIMS aims to strengthen its market presence in multiple states across India.